Back

Short tandem repeats significantly contribute to the genetic architecture of metabolic and sensory age-related hearing loss phenotypes

Ahmed, S.; Vaden, K. I.; Dubno, J. R.; Wright, G.; Drogemoller, B.

2026-02-18 genetic and genomic medicine
10.64898/2026.02.17.26346449 medRxiv
Show abstract

Age-related hearing loss (ARHL) is a progressive, bilateral decline in hearing ability that affects one in four individuals over 60 years of age worldwide. While previous genome-wide association studies (GWAS) have identified distinct single-nucleotide variants (SNVs) associated with metabolic and sensory ARHL phenotypes, the contribution of short tandem repeats (STRs) - a neglected yet important class of genetic variants - remains poorly understood. To address this gap, TRTools was used to impute STRs from a high quality, sequencing-derived SNV-STR reference panel to investigate the association between STRs and metabolic and sensory estimates. Heritability analyses revealed that while STRs contribute to estimates of both ARHL components, this class of variation plays a more important role in metabolic hearing loss (6%), which typically increases with age, compared to sensory hearing loss (4%). Further, the inclusion of this class of variant into GWAS analyses uncovered an association between a haplotype consisting of two missense variants (rs7714670 and rs6453022) and an intronic STR (chr5:73778077:A16) in ARHGEF28 (P=3.30x10-9), proving further insight into the variants driving this previously identified signal. Notably, burden analyses revealed that rare and longer repeats were associated with an increased risk of the metabolic phenotype and a reduced risk of the sensory phenotype. Functional annotation of significant and nominally significant STRs revealed potential effects on gene expression and splicing of nearby genes. Our findings provide the first evidence that STRs explain some of the missing heritability of ARHL phenotypes and create an STR resource for researchers to use in future analyses.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Aging Cell
144 papers in training set
Top 0.8%
8.3%
2
The American Journal of Human Genetics
206 papers in training set
Top 0.6%
8.3%
3
PLOS Genetics
756 papers in training set
Top 2%
8.3%
4
Human Molecular Genetics
130 papers in training set
Top 0.3%
6.7%
5
Nature Communications
4913 papers in training set
Top 30%
6.2%
6
Human Genetics
25 papers in training set
Top 0.1%
6.2%
7
Scientific Reports
3102 papers in training set
Top 25%
4.8%
8
Neurobiology of Aging
95 papers in training set
Top 0.8%
3.5%
50% of probability mass above
9
Nucleic Acids Research
1128 papers in training set
Top 7%
3.0%
10
Brain
154 papers in training set
Top 2%
3.0%
11
Communications Biology
886 papers in training set
Top 5%
2.1%
12
Frontiers in Genetics
197 papers in training set
Top 4%
2.1%
13
eLife
5422 papers in training set
Top 36%
2.0%
14
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 30%
1.9%
15
Genome Medicine
154 papers in training set
Top 4%
1.9%
16
npj Genomic Medicine
33 papers in training set
Top 0.4%
1.7%
17
Neurobiology of Disease
134 papers in training set
Top 3%
1.6%
18
Human Genomics
21 papers in training set
Top 0.1%
1.5%
19
Aging
69 papers in training set
Top 2%
1.5%
20
Human Genetics and Genomics Advances
70 papers in training set
Top 0.5%
1.2%
21
European Journal of Human Genetics
49 papers in training set
Top 0.9%
1.2%
22
iScience
1063 papers in training set
Top 23%
1.1%
23
PLOS ONE
4510 papers in training set
Top 64%
0.9%
24
Cell Genomics
162 papers in training set
Top 6%
0.8%
25
Clinical and Translational Medicine
30 papers in training set
Top 0.9%
0.8%
26
Cell Reports Medicine
140 papers in training set
Top 8%
0.7%
27
International Journal of Molecular Sciences
453 papers in training set
Top 16%
0.7%
28
Circulation: Genomic and Precision Medicine
42 papers in training set
Top 1%
0.7%
29
BMC Biology
248 papers in training set
Top 5%
0.7%
30
Frontiers in Aging Neuroscience
67 papers in training set
Top 4%
0.6%